Braskem Stock Forecast, Price & News

Braskem (NYSE:BAK) Frequently Asked Questions

Is Braskem a buy right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Braskem in the last twelve months. There are currently 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Braskem stock.
View analyst ratings for Braskem or view top-rated stocks.

What stocks does MarketBeat like better than Braskem?

Wall Street analysts have given Braskem a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Braskem wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Braskem's next earnings date?

Braskem is scheduled to release its next quarterly earnings announcement on Thursday, November 11th 2021.
View our earnings forecast for Braskem.

How were Braskem's earnings last quarter?

Braskem S.A. (NYSE:BAK) issued its quarterly earnings results on Tuesday, August, 3rd. The company reported $3.52 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $2.22 by $1.30. Braskem had a net margin of 11.24% and a negative trailing twelve-month return on equity of 811.92%.
View Braskem's earnings history.

How has Braskem's stock price been impacted by Coronavirus (COVID-19)?

Braskem's stock was trading at $9.21 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, BAK stock has increased by 135.7% and is now trading at $21.71.
View which stocks have been most impacted by COVID-19.

What price target have analysts set for BAK?

6 analysts have issued 12 month price targets for Braskem's stock. Their forecasts range from $14.00 to $32.00. On average, they anticipate Braskem's stock price to reach $22.00 in the next twelve months. This suggests a possible upside of 1.3% from the stock's current price.
View analysts' price targets for Braskem or view top-rated stocks among Wall Street analysts.

Who are Braskem's key executives?

Braskem's management team includes the following people:

• Roberto Lopes Pontes Simões, Chief Executive Officer & Director
• Pedro van Langendonck de Freitas, CFO, Head-Procurement & Institutional Relation
• Daniel Sales Corrêa, Head-Investments & Digital Technologies
• Artur Faria, Director-M&A, Business Development
• Marcelo Arantes de Carvalho, Head-People, Communications & Marketing

What is Roberto Lopes Pontes Simões' approval rating as Braskem's CEO?

31 employees have rated Braskem CEO Roberto Lopes Pontes Simões on Glassdoor.com. Roberto Lopes Pontes Simões has an approval rating of 100% among Braskem's employees. This puts Roberto Lopes Pontes Simões in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Braskem's key competitors?

Some companies that are related to Braskem include International Flavors & Fragrances (IFF), LyondellBasell Industries (LYB), Landstar (LDSR), Westlake Chemical (WLK), Braskem (BRKMY), Amyris (AMRS), Sensient Technologies (SXT), NewMarket (NEU), Methanex (MEOH), Renewable Energy Group (REGI), Codexis (CDXS), Green Plains (GPRE), Gevo (GEVO), Origin Materials (ORGN) and Cyclo Therapeutics (CTDH).
View all of BAK's competitors.

What other stocks do shareholders of Braskem own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Braskem investors own include Amarin (AMRN), Enterprise Products Partners (EPD), Micron Technology (MU), Pfizer (PFE), AT&T (T), AbbVie (ABBV), Aduro Biotech (ADRO), Armata Pharmaceuticals (ARMP), CRISPR Therapeutics (CRSP) and Chevron (CVX).

What is Braskem's stock symbol?

Braskem trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAK."

Who are Braskem's major shareholders?

Braskem's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (0.19%), Dimensional Fund Advisors LP (0.17%), JPMorgan Chase & Co. (0.05%), State Street Corp (0.04%), Renaissance Technologies LLC (0.02%) and Bank of Nova Scotia (0.01%).

Which major investors are selling Braskem stock?

BAK stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Citadel Advisors LLC, State Street Corp, Vanguard Group Inc., Dimensional Fund Advisors LP, and Goldman Sachs Group Inc..

Which major investors are buying Braskem stock?

BAK stock was purchased by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Bank of Nova Scotia, Invesco Ltd., TCW Group Inc., Renaissance Technologies LLC, Jump Financial LLC, Veriti Management LLC, and Comerica Bank.

How do I buy shares of Braskem?

Shares of BAK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Braskem's stock price today?

One share of BAK stock can currently be purchased for approximately $21.71.

How much money does Braskem make?

Braskem has a market capitalization of $8.65 billion and generates $11.37 billion in revenue each year. The company earns $-1,298,190,000.00 in net income (profit) each year or ($3.26) on an earnings per share basis.

How many employees does Braskem have?

Braskem employs 7,993 workers across the globe.

What is Braskem's official website?

The official website for Braskem is www.braskem.com.br.

Where are Braskem's headquarters?

Braskem is headquartered at Rua Lemos Monteiro 120 24 andar, Butanta D5, 05501-050.

How can I contact Braskem?

Braskem's mailing address is Rua Lemos Monteiro 120 24 andar, Butanta D5, 05501-050. The company can be reached via phone at 551135769735 or via email at [email protected].